Irvine, California-based Masimo Technologies, which makes non-invasive patient monitoring devices and sensors, has received FDA 510(k) clearance for its forehead sensor. The adhesive TFA-1 Forehead ...

IRVINE, Calif.-- (BUSINESS WIRE)-- Masimo (NASDAQ:MASI) announced today FDA 510 (k) clearance for the TFA-1™ Single-Patient-Use Adhesive Forehead Sensor. This single-patient-use sensor allows ...

Irvine, CA-based Masimo CorporationMASI recently announced that its TFA-1 Single-Patient-Use Adhesive Forehead Sensor has received a 5I0(k) clearance from the U.S. FDA. The sensor monitors patient's ...

Masimo Corp. in Irvine received FDA clearance for the sale of its TFA-1 Single-Patient-Use Adhesive Forehead Sensor. The forehead sensor measures oxygen saturation, similar to the company’s current ...

Masimo announced that the Food and Drug Administration (FDA) has granted clearance for the TFA-1 Single-Patient-Use Adhesive Forehead Sensor that allows clinicians to monitor patients using Masimo SET ...

Masimo announced today the CE marking of the reusable spot-check rainbow® Super DCI®-mini sensor, featuring Masimo SET® and rainbow SET™ technology.

Irvine, CA-based Masimo Corporation (NASDAQ:MASI) recently announced the receipt of CE mark for the noninvasive and reusable rainbow Super DCI-mini sensor. The sensor is based on the company’s ...

Masimo has earned a CE mark for a reusable finger sensor that noninvasively measures a range of physiological parameters at the same time. This reduces the need to use multiple sensors in patient ...

OBJECTIVE: Pulse oximetry is a standard of care for monitoring oxygenation in neonates. Associated with the use of pulse oximetry is the cost of patient sensors, especially if the sensor is designed ...